Investigator Initiated Studies & Research
The main purpose of the IIS Programme to increase and stimulate external research into products, therapies and clinical management, coordinated by healthcare professionals with support from Wellspect.
Advancing continence care is a joint endeavor between health care professionals, researchers and MedTech companies that are active in the field of continence care. Together, we can develop the next generation of bladder and bowel products and make a real difference in the lives of people who depend on such products.
While we conduct our own clinical research at Wellspect, we also fund clinical trials, study grants and Investigator Initiated Studies (IIS).
The main purpose of the IIS Programme to increase and stimulate external research into products, therapies and clinical management, coordinated by healthcare professionals with support from Wellspect.
Are you a nurse dedicated to helping patients with problems related to the bladder or bowel? Do you want to help patients all over the world, not only now, but also for future generations? As you know, today’s research leads to tomorrow’s clinical practice.
All products developed by Wellspect undergo clinical study programs whereby products' safety and performance are carefully evaluated and determined. Our clinical study programs are developed and conducted with lead clinicians in the field and in accordance with Good Clinical Practice (GCP).